XIDX
SPMA
Market cap82mUSD
Nov 12, Last price
278.00IDR
Name
Suparma Tbk PT
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Surabaya, Indonesia, PT Suparma Tbk, founded in 1976, specializes in the production and sale of diverse paper and packaging paper goods throughout Indonesia. Its offerings encompass various paper products, including laminated wrapping, brown Kraft, sandwiched ribbed Kraft recycle, white, and carton papers. The company also supplies a wide array of tissue products, such as bathroom, facial, napkin, and carrier tissues, as well as hand, hand roll, industrial and clinical roll, and kitchen towels. Furthermore, PT Suparma Tbk provides OEM products and engages in international export. The company transitioned to its current name, PT Suparma Tbk, in December 1978, having originally been known as PT Supar Inpama.
Key people
Welly
President Commissioner · since 2021
Edward Sopanan
President Director · since 2021
Barli Leoponco
Director · since 2021
Joseph Sulaiman
Director · since 2020
Hendro Luhur
Independent Director, Corporate Secretary · since 1998
Tan Juanto
Independent Commissioner · since 2014
M.B. Lanniwati
Independent Commissioner · since 2020
Subiantara
Independent Commissioner · since 2010
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||